Penn Center for Innovation

Latest Penn biotech spinout taking on cancer raises $1.6M from investors

Posted on April 2, 2020 — Jessica Jones Gupta

Another Philadelphia biopharmaceutical company spun out the University of Pennsylvania and targeting cancer has attracted a multimillion-dollar investment. Interius BioTherapeutics, founded by Dr. Saar Gill, raised $1.58 million from private investors in an equity financing.

Read more on the Philadelphia Business Journal

Category: external, news